Analogic (ALOG) Stock Rating Lowered by ValuEngine

Analogic (NASDAQ:ALOG) was downgraded by stock analysts at ValuEngine from a “buy” rating to a “hold” rating in a note issued to investors on Thursday.

Several other research firms have also commented on ALOG. Zacks Investment Research lowered shares of Analogic from a “buy” rating to a “hold” rating in a report on Wednesday, January 31st. BidaskClub raised shares of Analogic from a “strong sell” rating to a “sell” rating in a report on Friday, March 30th. Finally, TheStreet raised shares of Analogic from a “c+” rating to a “b-” rating in a report on Monday, April 2nd. One analyst has rated the stock with a sell rating, two have issued a hold rating and one has issued a strong buy rating to the stock. Analogic has an average rating of “Hold” and a consensus price target of $94.00.

NASDAQ:ALOG opened at $83.50 on Thursday. Analogic has a 52 week low of $66.00 and a 52 week high of $101.80. The stock has a market cap of $1,042.64, a P/E ratio of 37.07, a price-to-earnings-growth ratio of 2.82 and a beta of 0.62.



Analogic (NASDAQ:ALOG) last released its earnings results on Monday, March 5th. The medical research company reported $1.27 EPS for the quarter, beating the consensus estimate of $0.69 by $0.58. Analogic had a negative net margin of 15.34% and a positive return on equity of 6.05%. The firm had revenue of $129.20 million for the quarter, compared to analyst estimates of $112.50 million. During the same period last year, the firm earned $0.99 EPS. The business’s quarterly revenue was down 1.7% compared to the same quarter last year. analysts anticipate that Analogic will post 4.23 EPS for the current year.

Hedge funds have recently added to or reduced their stakes in the business. Legal & General Group Plc grew its holdings in shares of Analogic by 6.8% during the 3rd quarter. Legal & General Group Plc now owns 25,362 shares of the medical research company’s stock valued at $2,125,000 after purchasing an additional 1,613 shares during the last quarter. Schwab Charles Investment Management Inc. grew its holdings in shares of Analogic by 5.4% during the 3rd quarter. Schwab Charles Investment Management Inc. now owns 117,155 shares of the medical research company’s stock valued at $9,812,000 after purchasing an additional 6,029 shares during the last quarter. Dimensional Fund Advisors LP grew its holdings in shares of Analogic by 4.1% during the 3rd quarter. Dimensional Fund Advisors LP now owns 947,627 shares of the medical research company’s stock valued at $79,364,000 after purchasing an additional 37,066 shares during the last quarter. Piedmont Investment Advisors LLC bought a new stake in shares of Analogic during the 3rd quarter valued at approximately $227,000. Finally, Neuberger Berman Group LLC grew its holdings in shares of Analogic by 9.5% during the 3rd quarter. Neuberger Berman Group LLC now owns 336,517 shares of the medical research company’s stock valued at $28,183,000 after purchasing an additional 29,109 shares during the last quarter. 97.58% of the stock is currently owned by hedge funds and other institutional investors.

COPYRIGHT VIOLATION WARNING: This article was first published by Dakota Financial News and is the sole property of of Dakota Financial News. If you are reading this article on another site, it was stolen and reposted in violation of U.S. and international trademark and copyright legislation. The legal version of this article can be viewed at https://dakotafinancialnews.com/2018/04/14/analogic-alog-stock-rating-lowered-by-valuengine.html.

About Analogic

Analogic Corporation designs, manufactures, and sells medical imaging systems, ultrasound and security systems, and subsystems to original equipment manufacturers (OEMs) and end users primarily for the medical and airport security markets worldwide. It operates in three segments: Medical Imaging, Ultrasound, and Security and Detection.

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for Analogic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Analogic and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply